[HTML][HTML] A Canadian Simulation Model for Major Depressive Disorder: Study Protocol

S Ghanbarian, GWK Wong, M Bunka… - PharmacoEconomics …, 2024 - Springer
Background Major depressive disorder (MDD) is a common, often recurrent condition and a
significant driver of healthcare costs. People with MDD often receive pharmacological …

A Canadian Simulation Model for Major Depressive Disorder: Study Protocol.

S Ghanbarian, GWK Wong, M Bunka… - Pharmacoeconomics …, 2024 - europepmc.org
Background Major depressive disorder (MDD) is a common, often recurrent condition and a
significant driver of healthcare costs. People with MDD often receive pharmacological …

A Canadian Simulation Model for Major Depressive Disorder: Study Protocol

S Ghanbarian, GWK Wong, M Bunka… - … - pubmed.ncbi.nlm.nih.gov
Background Major depressive disorder (MDD) is a common, often recurrent condition and a
significant driver of healthcare costs. People with MDD often receive pharmacological …

A Canadian Simulation Model for Major Depressive Disorder: Study Protocol

S Ghanbarian, GWK Wong, M Bunka… - PharmacoEconomics …, 2024 - ideas.repec.org
Background Major depressive disorder (MDD) is a common, often recurrent condition and a
significant driver of healthcare costs. People with MDD often receive pharmacological …

A Canadian Simulation Model for Major Depressive Disorder: Study Protocol

S Ghanbarian, GWK Wong, M Bunka… - …, 2024 - econpapers.repec.org
Background Major depressive disorder (MDD) is a common, often recurrent condition and a
significant driver of healthcare costs. People with MDD often receive pharmacological …

[HTML][HTML] A Canadian Simulation Model for Major Depressive Disorder: Study Protocol

S Ghanbarian, GWK Wong, M Bunka… - PharmacoEconomics …, 2024 - ncbi.nlm.nih.gov
Background Major depressive disorder (MDD) is a common, often recurrent condition and a
significant driver of healthcare costs. People with MDD often receive pharmacological …

A Canadian Simulation Model for Major Depressive Disorder: Study Protocol.

S Ghanbarian, GWK Wong, M Bunka… - Pharmacoeconomics …, 2024 - europepmc.org
Background Major depressive disorder (MDD) is a common, often recurrent condition and a
significant driver of healthcare costs. People with MDD often receive pharmacological …